SciClone regulatory update

SciClone Pharmaceuticals Inc. (SCLN) SCLN filed for marketing approval in Hong Kong of Zadaxin thymosin alpha 1 to treat chronic hepatitis B and as a vaccine adjuvant in immunocompromised patients. T...